Cargando…

Delivering pharmacogenetic testing in a primary care setting

Pharmacogenetic testing refers to a type of genetic test to predict a patient’s likelihood to experience an adverse event or not respond to a given drug. Despite revision to several labels of commonly prescribed drugs regarding the impact of genetic variation, the use of this testing has been limite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mills, Rachel, Voora, Deepak, Peyser, Bruce, Haga, Susanne B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791676/ https://www.ncbi.nlm.nih.gov/pubmed/24101877 http://dx.doi.org/10.2147/PGPM.S50598

Ejemplares similares

Delivery of Pharmacogenetic Testing with or without Medication Therapy Management in a Community Pharmacy Setting
por: Haga, Susanne B, et al.
Publicado: (2021)

Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing
por: Haga, Susanne B, et al.
Publicado: (2021)

Pharmacogenetic information for patients on drug labels
por: Haga, Susanne B, et al.
Publicado: (2014)

Qualitative user evaluation of a revised pharmacogenetic educational toolkit
por: Mills, Rachel, et al.
Publicado: (2018)

Revisiting Secondary Information Related to Pharmacogenetic Testing
por: Haga, Susanne B.
Publicado: (2021)

Encountering Pharmacogenetic Test Results in the Psychiatric Clinic
por: Bousman, Chad A, et al.
Publicado: (2021)

Exploring Pharmacogenetic Testing for Hypertension Management in China
por: Zhao, Zhenping, et al.
Publicado: (2023)

Development and Initial Assessment of a Patient Education Video about Pharmacogenetics
por: Mills, Rachel, et al.
Publicado: (2017)

Survey of U.S. Public Attitudes Towards Pharmacogenetic Testing
por: Haga, Susanne B., et al.
Publicado: (2011)

The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
por: Haga, Susanne B.
Publicado: (2023)

A Mixed-Methods Protocol to Identify Best Practices for Implementing Pharmacogenetic Testing in Clinical Settings
por: Sperber, Nina R., et al.
Publicado: (2022)

United States Emergency Department Use of Medications with Pharmacogenetic Recommendations
por: Limkakeng, Alexander T., et al.
Publicado: (2021)

Pharmacogenetics of cancer therapy: breakthroughs from beyond?
por: Lu, Da-Yong, et al.
Publicado: (2015)

Pharmacogenetics and pharmacogenomics in glaucoma therapeutics: the way to personalized therapy
por: Liao, Shiyu, et al.
Publicado: (2023)

Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients
por: Li, Josephine H., et al.
Publicado: (2014)

Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings
por: Smith, D. Max, et al.
Publicado: (2020)

How informative is a negative finding in a small pharmacogenetic study?
por: Bacanu, S-A, et al.
Publicado: (2012)

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting
por: Cavallari, LH, et al.
Publicado: (2017)

Pharmacogenetics in the Management of Coumarin Anticoagulant Therapy: The Way Forward or an Expensive Diversion?
por: Greaves, Mike
Publicado: (2005)

Pharmacogenetics in Africa, an Opportunity for Appropriate Drug Dosage Regimens: on the Road to Personalized Healthcare
por: Masimirembwa, C, et al.
Publicado: (2013)

What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?
por: Jameson, Adam, et al.
Publicado: (2021)

Primary Care Physicians’ Knowledge, Attitudes, and Experience with Personal Genetic Testing
por: Haga, Susanne B., et al.
Publicado: (2019)

Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
por: Drozda, Katarzyna, et al.
Publicado: (2018)

Digital Technologies: Advancing Individualized Treatments through Gene and Cell Therapies, Pharmacogenetics, and Disease Detection and Diagnostics
por: Corridon, Peter R., et al.
Publicado: (2022)

Leadership, action, learning and accountability to deliver quality care for women, newborns and children
por: Adeniran, Abosede, et al.
Publicado: (2018)

Recent advances and future directions for the pharmacogenetic basis of anti-VEGF treatment response in neovascular age-related macular degeneration
por: Riaz, Moeen, et al.
Publicado: (2017)

The Management of Sickle Cell Disease in a Primary Care Setting
por: Humphreys, José V.A.
Publicado: (2012)

The Potential Utility of Pharmacogenetic Testing in Psychiatry
por: Gardner, Kathryn R., et al.
Publicado: (2014)

Trauma-Informed Care in Primary Health Settings—Which Is Even More Needed in Times of COVID-19
por: Tomaz, Teresa, et al.
Publicado: (2020)

A Call for Action to Safely Deliver Oral Health Care during and Post COVID-19 Pandemic
por: Farronato, Marco, et al.
Publicado: (2020)

Primary care and mental health providers’ perceptions of implementation of pharmacogenetics testing for depression prescribing
por: Vest, Bonnie M., et al.
Publicado: (2020)

Towards codesign in respiratory care: development of an implementation-ready intervention to improve guideline-adherent adult asthma care across primary and secondary care settings (The SENTINEL Project)
por: Crowther, Lucia, et al.
Publicado: (2022)

Pharmacogenetics in Primary Headache Disorders
por: Belyaeva, Irina I., et al.
Publicado: (2022)

Delivering effectively on large engineering projects
por: Madhavan, Guru, et al.
Publicado: (2023)

Institutions for health care price setting and regulation: A comparative review of eight settings
por: Barber, Sarah L., et al.
Publicado: (2019)

Outcomes Research on Telemedicine-Delivered Gender-Affirming Health Care for Transgender Youth Is Needed Now: A Call to Action
por: Stewart, Mary Kathryn, et al.
Publicado: (2023)

The landscape of pharmacogenetic testing in a US managed care population
por: Anderson, Heather D., et al.
Publicado: (2020)

Challenges in delivering rheumatology care during COVID-19 pandemic
por: Nune, A., et al.
Publicado: (2020)

Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings
por: Maciel, Alejandra, et al.
Publicado: (2018)

Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective
por: Rigter, Tessel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lj86nj1bujnt3u20u7b5vcivom